Roivant (ROIV) CIO sells shares after exercising $3.85 options
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) reported that President & CIO Mayukh Sukhatme exercised stock options and sold common shares over three days. On August 14, 17, and 18, 2026, options with a $3.85 exercise price were exercised to acquire an aggregate of 664,826 common shares, which were then sold in multiple open-market transactions at weighted average prices reported as approximately $36.23, $36.25, $36.59, and $37.18 per share, with actual trade prices ranging from $36.10 to $37.30, as described in the footnotes.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 664,826 shares ($21.60M approx. pre-tax spread)
Exercise and Sale
11 txns
Insider
Sukhatme Mayukh
Role
President & CIO
Sold
664,826 shs ($24.16M)
Approx. gross sale proceeds
$24.16M
Approx. exercise cost
$2.56M
Approx. pre-tax spread
$21.60M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Shares F5 | 136,942 | $0.00 | $0.00 |
| Exercise | Common Shares | 105,141 | $3.85 | $405K |
| Sale | Common Shares F3 | 105,141 | $36.59 | $3.85M |
| Exercise | Common Shares | 31,801 | $3.85 | $122K |
| Sale | Common Shares F4 | 31,801 | $37.18 | $1.18M |
| Exercise | Common Shares F5 | 284,707 | $0.00 | $0.00 |
| Exercise | Common Shares | 284,707 | $3.85 | $1.10M |
| Sale | Common Shares F2 | 284,707 | $36.25 | $10.32M |
| Exercise | Common Shares F5 | 243,177 | $0.00 | $0.00 |
| Exercise | Common Shares | 243,177 | $3.85 | $936K |
| Sale | Common Shares F1 | 243,177 | $36.23 | $8.81M |
Holdings After Transaction:
Common Shares — 32,190,276 shares (Direct)
Footnotes (5)
- F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $37.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F5. Award of stock options to purchase Common Shares that is fully vested.
Key Figures
Total shares sold: 664,826 shares
Option exercise price: $3.85 per share
Sale price (Aug 14 weighted average): $36.23 per share
+4 more
7 metrics
Total shares sold
664,826 shares
Aggregate common shares sold across all reported transactions
Option exercise price
$3.85 per share
Exercise or conversion price of stock options into common shares
Sale price (Aug 14 weighted average)
$36.23 per share
Weighted average sale price for 243,177 shares on August 14, 2026
Sale price (Aug 17 weighted average)
$36.25 per share
Weighted average sale price for 284,707 shares on August 17, 2026
Sale price (Aug 18 weighted averages)
$36.59 and $37.18 per share
Weighted average sale prices for 105,141 and 31,801 shares on August 18, 2026
Trade price ranges
$36.10–$37.30 per share
Ranges of individual trade prices across all sale tranches
Option expiration date
April 19, 2032
Expiration date of stock options that were exercised
Key Terms
weighted average price, stock options, derivative security, Common Shares
4 terms
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
stock options financial
"Award of stock options to purchase Common Shares that is fully vested."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transactions did ROIV executive Mayukh Sukhatme report in this Form 4?
Mayukh Sukhatme reported option exercises and related sales of 664,826 Roivant Sciences (ROIV) common shares on August 14, 17, and 18, 2026. The shares were acquired via options at $3.85 per share and sold in multiple open-market transactions.
What was the option exercise price in Mayukh Sukhatme’s ROIV Form 4 transactions?
The stock options exercised by Mayukh Sukhatme carried an exercise price of $3.85 per common share. These fully vested options were exercised on August 14, 17, and 18, 2026, and the resulting shares were then sold in separate open-market transactions.
Over what dates did the reported ROIV insider transactions occur?
The reported transactions occurred on August 14, 17, and 18, 2026. Across these three days, Mayukh Sukhatme exercised vested stock options at $3.85 per share and sold the resulting 664,826 common shares in multiple trades.
Were the ROIV insider sales reported as weighted average prices?
Yes. Each sale line item reports a weighted average price with detailed ranges. Footnotes state that shares were sold in multiple transactions, with prices ranging from $36.10 to $37.30, and that full trade-by-trade details are available upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
